2011 53rd ASH Annual Meeting – účast ČR

102. Regulation of Iron Metabolism: Poster II

Erythropoietin-Driven Signaling Complements the Survival Defect of DMT1-Mutant Erythroid Cells

Autoři: Mgr. Monika Horváthová, Ph.D.; Mgr. Katarína Kapraľová; Mgr. Zuzana Židová; MvDr. Dalibor Doležal; doc.MUDr. Dagmar Pospíšilová, Ph.D.; Doc.RNDr. Vladimír Divoký, Ph.D.
Číslo abstraktu: 2104
Kategorie: Podpůrná onkologická léčba, výživa nemocných a ošetřovatelská péče

311. Disorders of Platelet Number or Function: Poster III

Final Results from an International, Multi-Center, Single-Arm Study Evaluating the Safety and Efficacy of Romiplostim in Adults with Primary Immune Thrombocytopenia (ITP)

Autoři: MD Ann Janssens; MD Michael D. Tarantino; MD Robert Bird; MD Maria Gabriella Mazzucconi; Ralph Vincent V. Boccia, MD; MD Maria Fernanda Lopez-Fernandez; doc. MUDr. Tomáš Kozák, Ph.D., MBA; MD Michael Steurer; MD Peter A.W. Te Boekhorst, PhD; Kerry Dillingham, MSc; MD Richard Lizambri
Číslo abstraktu: 3279
Kategorie: Maligní lymfomy a leukémie

322. Disorders of Coagulation or Fibrinolysis: Poster III

Safety of Recombinant Activated Factor VII (rFVIIa) in Patients with Congenital Hemophilia with Inhibitors: Overall Dose Exposure and Intervals Following >240 Mcg/Kg Doses Across Trial, Registry and Diary Studies

Autoři: MD Amy D. Shapiro; MD Ellis J. Neufeld, PhD; MD Victor S. Blanchette, FRCPC; MD Hervé Chambost, PhD; MUDr. Peter Salaj; MD Robert Z. Gut, PhD; MD David L. Cooper, MBA
Číslo abstraktu: 3316
Kategorie: Podpůrná onkologická léčba, výživa nemocných a ošetřovatelská péče

331. Pathophysiology of Thrombosis: Poster III

Risk Factors of Thromboembolic Events in Multiple Myeloma Treated with IMiDs-Based Therapy While on LMWH Prophylaxis

Autoři: MD Xavier Leleu, PhD; Simona Iacobelli, Ph.D.; Alain Barrois; Benjamin Pelle; Liz Clark; MD Eileen Boyle; Prof. MD Philippe Moreau; MD Mamoun Dib; MD Denis Caillot; MD Dietger W Niederwieser; MD Tamas Masszi, PhD; MD Jean Fontan; MD Chantal Doyen; prof. MUDr. Roman Hájek, CSc.; Francesco Onida; Prof. MD Heinz Ludwig; MD Theo M. de Witte; MD Gosta Gahrton; MD Curly TCM Morris; MD Laurent Garderet
Číslo abstraktu: 3340
Kategorie: Mnohočetný myelom

508. Bone Marrow Failure: Poster I

Changes Identified by Flow Cytometry and WT1 Expression in Consecutive Bone Marrow Samples in Refractory Cytopenia of Childhood and Aplastic Anemia Before Start of the Therapy

Autoři: MUDr. Michaela Reiterová; Mgr. Karolina Škvárová Kramarzová, Ph.D.; MUDr. Martina Suková; MUDr. Vít Campr, Ph.D.; MUDr. Elena Vodičková; MUDr. Ondřej Zapletal, Ph.D.; MUDr. Jan Blatný, Ph.D.; Doc.RNDr. Zuzana Zemanová, CSc.; RNDr. Libuše Lizcová; Vendula Pelková (Macečková); Prof.MUDr. Jan Trka, Ph.D.; prof. MUDr. Jan Starý, DrSc.; Prof. MUDr. Ondřej Hrušák, Ph.D.; MUDr. Ester Mejstříková, Ph.D.
Číslo abstraktu: 1342
Kategorie: Maligní lymfomy a leukémie

602. Disordered Gene Expression in Hematologic Malignancy, including Disordered Epigenetic Regulation: Poster I

The Potential Role of the Six1/Eya1 Pathway in the Establishment of Leukemia Stem Cells in MLL-ENL – Induced Leukemia

Autoři: Mgr. Sylvia Takáčová, Ph.D.; Mgr. Pavla Lužná; Mgr. Viktor Stránecký; Doc.RNDr. Vladimír Divoký, Ph.D.
Číslo abstraktu: 1362
Kategorie: Maligní lymfomy a leukémie

603. Oncogenes and Tumor Suppressors: From Genomic-based Discovery to Functional Validation

The Genomic Landscape of TEL-AML1+ (ETV6-RUNX1) Acute Lymphoblastic Leukaemia

Autoři: Elli Papaemmanuil, Ph.D.; Inmaculada Rapado; Anthony M. Ford; Keiran Raine; Jonathan Hinton; David Jones; John Marshall; Laura J. Mudie; prof. MUDr. Jan Zuna, Ph.D.; Giovanni (Gianni) Cazzaniga, PhD; Helena Kempski; Maria do Soccoro Pombo-de-Oliveira, PhD; Mike R. Stratton; P. Andrew Futreal; Peter Campbell; Mel Greaves
Číslo abstraktu: 403
Kategorie: Maligní lymfomy a leukémie

604. Molecular Pharmacology, Drug Resistance: Poster II

The Gene Expressions of hOCT1 and ABCB1 Change During the Course of CML in Relation to Imatinib Therapy

Autoři: Mgr. Kateřina Machová (Poláková), Ph.D.; RNDr. Jitka Koblihová, Ph.D.; RNDr. Zuzana Ondráčková; Ing. Filip Rázga, Ph.D.; Mgr. Václava Polívková (Zmeková); MUDr. Hana Klamová, CSc.; MUDr. Daniela Žáčková, Ph.D.; prof. MUDr. Petr Cetkovský, Ph.D.; Prof. MUDr. Marek Trněný, CSc.; prof. MUDr. Jiří Mayer, CSc.; Prof. MUDr. Zdeněk Ráčil, Ph.D.
Číslo abstraktu: 2495
Kategorie: Maligní lymfomy a leukémie

611. Leukemias - Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis: Poster II

Expression Pattern of WT1 Isoforms in Patients with Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) and Severe Aplastic Anemia (SAA)

Autoři: Mgr. Karolina Škvárová Kramarzová, Ph.D.; MD Andre Willasch, PhD; Dr. Bernd Gruhn; MUDr. Jiří Schwarz, CSc.; Ing. Jana Marková; prof. MUDr. Jan Starý, DrSc.; Prof.MUDr. Jan Trka, Ph.D.; MUDr. Ludmila Boublíková, Ph.D.
Číslo abstraktu: 2502
Kategorie: Maligní lymfomy a leukémie

Five-Color Multiplex Real-Time PCR Technology to Detect Over 75 Recurrent Chromosomal Abnormalities in Acute Myeloid Leukemia; Benefits for Minimal Residual Disease Detection

Autoři: Mgr. Radek Plachý, Ph.D.; Lenka Zejsková; Radek Čmejla, PhD; David Warren Hardekopf; Tereza Jančušková; Lucie Krutílková; MUDr. Michal Karas; MUDr. Vladimír Koza (1954 - 2012); MUDr. Jan Vydra; Prof. MUDr. Pavel Žák, Ph.D.; MUDr. Lukáš Smolej, Ph.D.; MUDr. Soňa Peková (Chambon), Ph.D.
Číslo abstraktu: 2526
Kategorie: Maligní lymfomy a leukémie

International Standardization of Minimal Residual Disease Assessment for in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL) Expressing m-BCR-ABL Transcripts: Updated Results of Quality Control Procedures by the EWALL and ESG-MR

Autoři: MD Heike Pfeifer; Giovanni (Gianni) Cazzaniga, PhD; Dr. ssa Orietta Spinelli, PhD, BiolSC; Jean-Michel Cayuela, PhD.; Dr. Helene Cavé; MD Peter Vandenberghe (Vandenberge), Ph.D.; Carmen Chillon; MD Tomasz Sacha; Sandrine Hayette, Ph.D.; Silja Roettgers, Ph.D.; Prof. MD Thomas Lion, PhD; MD Letizia Foroni, PhD; Vincent H.J. Van der Velden, PhD; prof. MUDr. Jan Zuna, Ph.D.; Monica Hermanson, PhD; Martin Christian Mueller, MD; MD Thoralf Lange; MD Miroslaw Majewski; MD Israel Bendit; MD Fabrizio Pane; Ilaria Iacobucci, PhD; MD Veli Kairisto, PhD; Christa Homburg; Smadar Avigad, PhD; M.D. Allen Eng Juh Yeoh; Beat Schäfer; MB BS Adele Fielding, PhD; Loredana Elia; Katarzyna Borg; Eric Delabesse; Prof. Dr. Susanne Schnittger, PhD; Sandra Markovic; Volker Werner; MD Nicola Goekbuget; Prof. MUDr. Dieter Hoelzer, Dr. h.c.; MD Jacques J.M. van Dongen, PhD; MD Oliver G. Ottmann, PhD
Číslo abstraktu: 2535
Kategorie: Maligní lymfomy a leukémie

New Targets in Cytometric Investigation of Acute Leukemia Selected From Gene Profiling Studies

Autoři: Mgr. Martina Vášková; MUDr. Ester Mejstříková, Ph.D.; Mgr. Tomáš Brdička; RNDr. Pavla Angelisová, CSc.; prof. MUDr. Tomáš Kalina, Ph.D.; Mgr. Veronika Kanderová; Mgr. Daniela Kužílková; Mgr. Martin Kováč; Prof.MUDr. Jan Trka, Ph.D.; MD Fridtjof Lund-Johansen, PhD; prof. MUDr. Jan Starý, DrSc.; Prof. MUDr. Ondřej Hrušák, Ph.D.
Číslo abstraktu: 2536

612. Acute Lymphoblastic Leukemia - Biology and Pathophysiology: Biology, Microenvironment and Treatment Stratification

Repeated Bone Marrow Aspiration At the End of Induction Therapy: Implications for Treatment Stratification in Paediatric Acute Lymphoblastic Leukaemia

Autoři: prof. MUDr. Jan Zuna, Ph.D.; Mari Arens; Dr. phil. nat. Rolf Koehler, PhD; MD Renate Panzer-Grümayer; MD Anja Möricke; Prof. MD Claus R. Bartram; Ruth Joas; MUDr. Eva Froňková, Ph.D.; MD Gunnar Cario; MD Martin Stanulla, MSc; Martin Zimmermann, Ph.D.; Prof.MUDr. Jan Trka, Ph.D.; prof. MUDr. Jan Starý, DrSc.; MD Andische Attarbaschi, PhD; MD Georg Mann; MD Martin Schrappe; MD André Schrauder
Číslo abstraktu: 756
Kategorie: Maligní lymfomy a leukémie

614. Acute Lymphoblastic Leukemia - Therapy, excluding Transplantation: Clinical Trials

Conventional Reinduction/Consolidation-Type Therapy Versus Short Course High Intensity Combination Chemotherapy As Post-Induction Treatment for Children with Relapsed Acute Lymphoblastic Leukemia. Early Results of Study ALL-REZ BFM 2002

Autoři: MD Arend von Stackelberg; MD Junko Yamanaka; MD Gabriele Escherich; Dr. Cornelia Eckert, PhD; MD Richard Ratei; MD Johann K. Hitzler; MD Georg Mann; Doc. MUDr. Lucie Šrámková, Ph.D.; MD Jean-Pierre Bourquin, PhD; MD Martin Schrappe; MD Günter Henze
Číslo abstraktu: 871
Kategorie: Maligní lymfomy a leukémie

Results of the Randomized I-BFM-SG Trial „Acute Lymphoblastic Leukemia Intercontinental-BFM 2002“ in 5060 Children Diagnosed in 15 Countries on 3 Continents

Autoři: prof. MUDr. Jan Starý, DrSc.; Martin Zimmermann, Ph.D.; Myriam Campbell; Luis Castillo; Eduardo Dibar; Svetlana Donska; Alejandro Gonzales; MD Shai Izraeli; Dragana Janic; Janez Jazbec; Josip Konja; Doc. MUDr. Emilia Kaiserová, CSc.; Jerzy Kowalczyk; Gabor Kovacs; MD Chi Kong Li, MBBS; Edina Magyarosy; Alexander Popa; MD Batia Stark; MUDr. Yahia Jabali; Prof.MUDr. Jan Trka, Ph.D.; Prof. MUDr. Ondřej Hrušák, Ph.D.; Mgr. Iveta Janotová; Hansjörg Riehm; Giuseppe Masera; MD Martin Schrappe
Číslo abstraktu: 872
Kategorie: Maligní lymfomy a leukémie

Efficacy and Safety of Imatinib on Top of BFM-Like Chemotherapy in Pediatric Patients with Ph+/BCR-ABL+ Acute Lymphoblastic Leukemia (Ph+ALL). the EsPhALL Study

Autoři: MD Andrea Biondi; MD Martin Schrappe; Paola de Lorenzo, PhD; Anders Castor; Giovanna Lucchini; MD Virginie Gandemer; Prof. MD Rob Pieters, PhD; prof. MUDr. Jan Starý, DrSc.; MD Gabriele Escherich; Myriam Campbell; MD Chi Kong Li, MBBS; prof. MUDr. Ajay J. Vora, MD, FRCP, FRCPath; Gudmar Lonnerholm; Maurizio Arico; Jochen Harbott; Prof. Vaskar Saha, PhD, FRCP, FRCPath; Prof. Maria Grazia Valsecchi, PhD
Číslo abstraktu: 873
Kategorie: Maligní lymfomy a leukémie

622. Non-Hodgkin Lymphoma - Biology, excluding Therapy: Molecular Mechanisms and Profiling

SNP-Arrays Provide New Insights Into the Pathogenesis of Richter Syndrome (RS)

Autoři: Andrea Rinaldi; Ekaterina Chigrinova; Ivo Kwee; M.D. Davide Rossi; Paola MV Rancoita, PhD; BSc. Jonathan C. Strefford, PhD; Prof. David Graham Oscier; MD Kostas Stamatopoulos; MD Theodora Papadaki, Ph.D.; MD Francoise Berger; MD Ken H. Young; Fiona Murray; Prof. MD Richard Rosenquist (Brandell), PhD; MD Timothy C. Greiner; MD Wing C. Chan; Luca Arcaini; Marco Lucioni; M.D. Roberto Marasca; Giorgio Inghirami; Dr. Marco Ladetto; Francesco Forconi; Sergio Cogliatti; RNDr. Hana Bruchová Votavová, Ph.D.; MD Steven H. Swerdlow; MD Stephan Stilgenbauer; MD Miguel Angel Piris; MD Andras Matolcsy; Dominic Spagnolo; Eugene Nikitin; Alberto Zamo; Valter Gattei; MD Laura Pasqualucci; Emanuel Zucca; Gianluca Galdano; Francesco Bertoni
Číslo abstraktu: 263
Kategorie: Maligní lymfomy a leukémie

622. Non-Hodgkin Lymphoma - Biology, excluding Therapy: Poster III

Symptoms and Toxicity of Rituximab Maintenance (R-M) Versus Observation (OBS) Following Rituximab Plus Chemotherapy in Patients with Follicular Lymphoma

Autoři: Xiaolei Zhou; Jianmin Wang; Jessica Zhang; Catherine Copley-Merriman; Yasuhiro Torigoe; Carolina Reyes; Prof. John Francis Seymour, MD, PhD, MBBS, FRACP; MD Armando Lopez-Guillermo; MD Fritz C. Offner, PhD; Prof. MUDr. Marek Trněný, CSc.; MD Gilles Andre Salles, PhD
Číslo abstraktu: 3661
Kategorie: Maligní lymfomy a leukémie

MicroRNA Analysis in the Cerebrospinal Fluid and Blood Serum of Lymphoma Patients At Diagnosis and in Response to Therapy

Autoři: Mgr. Vít Pospíšil; MUDr. Heidi Móciková, Ph.D.; MUDr. Milada Jankovská; MUDr. Jana Marková; MUDr. Ľubica Gaherová; doc. MUDr. Tomáš Kozák, Ph.D., MBA; Doc. MUDr. Tomáš Stopka, Ph.D.
Číslo abstraktu: 3663
Kategorie: Maligní lymfomy a leukémie

623. Lymphoma - Chemotherapy, excluding Pre-Clinical Models: Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma

Reduced Intensity of Chemotherapy and PET-Guided Radiotherapy in Patients with Advanced Stage Hodgkin Lymphoma: The GHSG HD15 Final Results

Autoři: Prof. MD Andreas Engert; Heinz Haverkamp; MD Carsten Kobe; Ing. Jana Marková; MD Christoph Renner; Prof.MD Anthony D. Ho, PhD, FRCP; Jose Zijlstra, MD; MUDr. Zdeněk Král, Ph.D.; MD Harald Stein; MD Hans Theodor Eich; MD Rolf Peter Müller; MD Markus Dietlein; MD Peter Borchmann, PhD; MD Volker Diehl
Číslo abstraktu: 589
Kategorie: Maligní lymfomy a leukémie

623. Lymphoma - Chemotherapy, excluding Pre-Clinical Models: Poster II

Final Results of the Phase II SAPHIRE Trial of Resminostat (4SC-201) in Patients with Relapsed/Refractory Hodgkin Lymphoma

Autoři: MD Jan Andrzej Walewski, Ph.D.; Ewa Paszkiewicz-Kozik; Agnieszka Warszewska; Dr. Gabriela Borsaru; Andreea Moicean; MD Andrzej Hellmann, Ph.D.; prof. MUDr. Jiří Mayer, CSc.; Bernhard Hauns; Anna Mais; Stefan W. Henning; Bernd Hentsch
Číslo abstraktu: 2675
Kategorie: Maligní lymfomy a leukémie

624. Lymphoma - Therapy with Biologic Agents, excluding Pre-Clinical Models: Mantle Cell and T Cell Lymphoma - Targeted Antibody and Small Molecule Approaches

R-CHOP Versus R-FC Followed by Maintenance with Rituximab Versus Interferon-Alfa: Outcome of the First Randomized Trial for Elderly Patients with Mantle Cell Lymphoma

Autoři: Johanna C. Kluin-Nelemans; Eva Hoster; MD Jan Andrzej Walewski, Ph.D.; MD Stephan Stilgenbauer; MD Christian H. Geisler, PhD; MD Christian Gisselbrecht; MD Ursula Vehling-Kaiser; MD Jeanette K Doorduijn, PhD; Prof. MUDr. Marek Trněný, CSc.; MD Bertrand Coiffier; MD R. Forstpointner; MD Herve Tilly; MD Lothar Kanz; MD M. Szymczyk; Prof. Olivier Hermine, M.D., PhD; MD Wolfram Klapper, PhD; MD Wolfgang Hiddemann; MD Michael Unterhalt, PhD; MD Martin H. Dreyling, Ph.D.
Číslo abstraktu: 439
Kategorie: Maligní lymfomy a leukémie

631. Chronic Myeloid Leukemia - Biology and Pathophysiology, excluding Therapy: Poster III

Cytogenetic Aberration Profile of Chronic Myeloid Leukemia and Its Dynamic Changes During Imatinib Therapy

Autoři: Jelena D. Milosevic (Feenstra), Ph.D.; Ing. Filip Rázga, Ph.D.; Ing. Dana Dvořáková, CSc.; Mgr. Tomáš Jurček; Tiina Berg; Ana Puda; Thorsten Klampfl; Ashot Harutyunyan; Bettina Gisslinger; MD Heinz Gisslinger; Ester Orlandi; Paolo Bernasconi; prof. MUDr. Karel Indrák, DrSc.; RNDr. Martina Divoká; prof. MUDr. Edgar Faber, CSc.; prof. MUDr. Jiří Mayer, CSc.; Prof. MUDr. Zdeněk Ráčil, Ph.D.; Robert Kralovics, PhD
Číslo abstraktu: 3755
Kategorie: Maligní lymfomy a leukémie

632. Chronic Myeloid Leukemia - Therapy: Poster I

Outcome of Patients with Chronic Myeloid Leukemia After Allogeneic Stem Cell Transplantation in Europe; Data From the EUTOS for CML Registry

Autoři: MD Susanne Saussele; Dr. rer. biol. hum. Verena Sophia Hoffmann, BSc, M.A.; Dipl. Inf. Doris Lindörfer (Lindoerfer); MD Andreas Hochhaus; MD Francisco Cervantes; MD Gert (J.) Ossenkoppele, PhD; M.D. Henrik Hjort-Hansen, Ph.D.; Prof. Dr. Steve (Stephen) O'Brien, PhD; prof. MUDr. Jiří Mayer, CSc.; prof. MUDr. Karel Indrák, DrSc.; MD Andrzej Hellmann, Ph.D.; Dr. Adriana Colita; MD Anna Turkina, PhD; MD Andrey Zaritsky (Zaritskey); MD Juan Luis Steegmann, PhD; M.D. David Marin; Dr. rer. biol. hum. Markus Pfirrmann, M.Sc.; MD Michele Baccarani; Joelle Guilhot (Guillhot), PhD; MD Joerg Hasford; MD Carmen Piccolo; MD Bengt Simonsson, PhD; Prof. Dr. Rüdiger Hehlmann; Prof. MD Gianantonio Rosti
Číslo abstraktu: 1688
Kategorie: Maligní lymfomy a leukémie

633. Myelodysplastic Syndromes: Poster II

Transfusion-Dependency Is the Most Important Prognostic Factor for Survival in 1000 Newly Diagnosed MDS Patients with Low- and Intermediate-1 Risk MDS in the European LeukemiaNet MDS Registry

Autoři: MD Louise de Swart; Alexandra Smith; MD Pierre Fenaux, PhD; MD David Bowen, Ph.D.; MD Guillermo F Sanz, PhD; MD Eva Hellström-Lindberg; Dr. Argyris Symeonidis, Ph.D.; prof. MUDr. Jaroslav Čermák, CSc.; MD Ulrich Germing; MD Reinhard Stauder; Otilia Georgescu; Marius MacKenzie; MD Luca Malcovati; MD Mette Skov-Holm, PhD; Sophie Park; Odile Beyne-Rauzy; Jackie Droste; MD Theo de Witte, PhD
Číslo abstraktu: 2775
Kategorie: Myelodysplastický syndrom

Mutations of the Spliceosome Complex Genes Occur In Adult Patients but Are Very Rare In Children with Myeloid Neoplasia

Autoři: MD Shinsuke Hirabayashi; Jessica Moetter, PhD; MD Kenichi Yoshida; MD Michael Heuser; Prof. MD Henrik Hasle; Alexandra Fischer, R.N.; MD Brigitte Strahm; Prof. MD Brigitte M. Schlegelberger; MD Irith Baumann; MD Felicitas Thol; prof. MUDr. Jan Starý, DrSc.; Prof. MD Franco Locatelli, PhD; MD Marco Zecca; MD Markus Schmugge (Schmugge-Liner); Prof. MD Michael Dworzak; MD Marry M. van den Heuvel-Eibrink, PhD; MD Barbara De Moerloose; MD Seishi Ogawa, PhD; prof. MD Christian M. Flotho; Prof. MD Charlotte M. Niemeyer, PhD; MD Marcin W. Wlodarski
Číslo abstraktu: 2797
Kategorie: Myelodysplastický syndrom

633. Myelodysplastic Syndromes: Poster III

IER3 Expression in Childhood Myelodysplastic Syndrome

Autoři: MD Andrica de Vries; MD Christian Michel Zwaan, PhD; Astrid A Danen-van Oorschot, PhD; MD Valerie de Haas, Ph.D.; Prof. MD Henrik Hasle; Prof. MD Franco Locatelli, PhD; MD Barbara De Moerloose; MD Sophia Polychronopoulou, Ph.D.; prof. MUDr. Jan Starý, DrSc.; MD Markus Schmugge (Schmugge-Liner); Prof. MD Michael Dworzak; MD Marco Zecca; H.Berna Beverloo, PhD; Prof. MD Charlotte M. Niemeyer, PhD; Prof. MD Rob Pieters, PhD; MD Marry M. van den Heuvel-Eibrink, PhD
Číslo abstraktu: 3817
Kategorie: Myelodysplastický syndrom

The Significance of Megakaryocytic Transcription Factor Fli1 and Erythroid Transcription Factor EKLF in the Ribosomopathies: 5q Minus Syndrome and Diamond-Blackfan Anemia. the Role of Fli1 in p53 Regulation and in 5q Minus Syndrome Megakaryopoiesis

Autoři: doc. MUDr. Radana Neuwirtová, CSc.; Ing. Ota Fuchs, CSc.; doc.MUDr. Dagmar Pospíšilová, Ph.D.; RNDr. Radek Čmejla, Ph.D.; Mgr. Monika Holická; Mgr. Martin Vostrý; Mgr. Arnošt Kostečka; Mgr. Hana Hájková; doc. MUDr. Anna Jonášová, Ph.D.; prof. MUDr. Jaroslav Čermák, CSc.; prof. Ing. Kyra Michalová, DrSc.; RNDr. Jana Březinová, Ph.D.
Číslo abstraktu: 3825
Kategorie: Myelodysplastický syndrom

634. Myeloproliferative Syndromes: Poster II

First Achievements of MPN&MPNr-EuroNet (COST Action BM0902), a New European Network Dedicated to the Diagnosis of Myeloproliferative Neoplasms and Hereditary Erythrocytosis and Thrombocytosis

Autoři: MD Sylvie Hermouet, PhD; MD Eric Lippert, PhD; Niels Pallisgaard; MUDr. Jiří Schwarz, CSc.; MD Mary Frances McMullin; MD Lars Palmqvist, PhD; Heike L. Pahl, PhD; Beatriz Bellosillo Paricio; Celeste Bento; Serge Carillo; MD Stephane Giraudier, PhD; MD Francois Girodon, PhD; Melanie Percy, PhD, FRCPath; Prof. MUDr. Lukáš Plank, CSc.; Prof. Dr. Susanne Schnittger, PhD; MD Radek C. Skoda; MD Alessandro M. Vannucchi
Číslo abstraktu: 2809
Kategorie: Myeloproliferativní nemoci; Zhoubné gynekologické nádory

634. Myeloproliferative Syndromes: Poster III

Activation of Chromatin Structure Upstream PU.1 Gene and in Vitro Differentiation in High Risk Myelodysplastic Syndrome Following 5-Azacytidine

Autoři: Doc. MUDr. Tomáš Stopka, Ph.D.; Mgr. Nikola Čuřík, Ph.D.; Mgr. Pavel Burda, Ph.D.; Mgr. Karina Vargová, Ph.D.; Mgr. Vít Pospíšil; Mgr. Petra Vlčková (Bašová); Bc. Filipp Savvulidi; Prof. MUDr. Emanuel Nečas, DrSc.; Mgr. Hana Hájková; RNDr. Cedrik Haškovec, CSc.; Mgr. Monika Běličková; prof. MUDr. Jaroslav Čermák, CSc.; Prof. MUDr. Marek Trněný, CSc.; doc. MUDr. Anna Jonášová, Ph.D.
Číslo abstraktu: 3791
Kategorie: Myelodysplastický syndrom

Thrombosis in MPN with Thrombocythemia Is Associated with Higher Platelet Count At the Time of the Event: Data From the Czech Registry of Patients Treated with Anagrelide

Autoři: MUDr. Jiří Schwarz, CSc.; prof. MUDr. Miroslav Penka, CSc.; Mgr. Petra Ovesná, Ph.D.; MUDr. Olga Černá; MUDr. Yvona Brychtová, Ph.D.; Doc. MUDr. Petr Dulíček, Ph.D.
Číslo abstraktu: 3857
Kategorie: Myelodysplastický syndrom

Interlaboratory Quality Control Round of MPL Mutation Detection in Fourteen European Laboratories: A MPN&MPNr-EuroNet Study

Autoři: Naomi A. Porret, PhD; Elisabeth Oppliger Leibundgut, PharmD; Serge Carillo; PharmD Bruno Cassinat, PhD; MD Francois Girodon, PhD; MD Eric Lippert, PhD; MD Valérie Ugo, PhD; MD Sylvie Hermouet, PhD; MD Paola Guglielmelli; MUDr. Jiří Schwarz, CSc.; Beatriz Bellosillo Paricio; Prof. Dr. Susanne Schnittger, PhD; Maj K. Westman; MD Stephane Giraudier, PhD
Číslo abstraktu: 3859
Kategorie: Myelodysplastický syndrom

641. CLL - Biology and Pathophysiology, excluding Therapy: Poster I

Mutational Analysis of Mir-29 Family Members in Chronic Lymphocytic Leukemia

Autoři: PharmDr. Jana Lochmanová; MUDr. Mgr. Marek Mráz, Ph.D.; Mgr. Veronika Navrkalová, Ph.D.; Mgr. Barbora Dvořáková; MvDr. Boris Tichý, Ph.D.; Mgr. Karla Plevová, Ph.D.; RNDr. Ludmila Šebejová; RNDr. Jitka Malčíková, Ph.D.; Mgr. Šárka Pavlová, PhD; Vladimir Benes; Dr. Tobias Rausch; MUDr. Yvona Brychtová, Ph.D.; prof. MUDr. Michael Doubek, Ph.D.; Doc. MUDr. Martin Trbušek, PhD; prof. MUDr. Jiří Mayer, CSc.; prof. RNDr. Šárka Pospíšilová, Ph.D.
Číslo abstraktu: 1770
Kategorie: Maligní lymfomy a leukémie

641. CLL - Biology and Pathophysiology, excluding Therapy: Poster II

Improving Survival in Patients with Chronic Lymphocytic Leukemia - Population Based Study

Autoři: Prof. MUDr. Marek Trněný, CSc.; MUDr. Petra Obrtlíková, Ph.D.; MUDr. Jiří Schwarz, CSc.; RNDr. Tomáš Pavlík, Ph.D.; RNDr. Jan Mužík, Ph.D.; Prof. RNDr. Ladislav Dušek, Ph.D.
Číslo abstraktu: 2852

641. CLL - Biology and Pathophysiology, excluding Therapy: Poster III

The Regulation, Targets and Clinical Relevance of Microrna Mir-650 in Chronic Lymphocytic Leukemia (CLL)

Autoři: MUDr. Mgr. Marek Mráz, Ph.D.; Mgr. Karla Plevová, Ph.D.; Mgr. Dáša Doležalová; Mgr. Kateřina Staňo Kozubík; Bc. Veronika Mayerová; Kateřina Černá; Mgr. Kateřina Musilová; Mgr. Šárka Pavlová, PhD; MvDr. Boris Tichý, Ph.D.; PharmDr. Jana Lochmanová; prof. MUDr. Michael Doubek, Ph.D.; MUDr. Yvona Brychtová, Ph.D.; Doc. MUDr. Martin Trbušek, PhD; Doc. MvDr. Aleš Hampl, CSc.; prof. MUDr. Jiří Mayer, CSc.; prof. RNDr. Šárka Pospíšilová, Ph.D.
Číslo abstraktu: 3874
Kategorie: Maligní lymfomy a leukémie

642. CLL - Therapy, excluding Transplantation: First line therapy

Immunochemotherapy with Low-Dose Subcutaneous Alemtuzumab (A) Plus Oral Fludarabine and Cyclophosphamide (FC) Is Safe and Induces More and Deeper Complete Remissions in Untreated Patients with High-Risk Chronic Lymphocytic Leukemia (CLL) Than Chem...

Autoři: MD Christian H. Geisler, PhD; MD Mars MB van 't Veer, PhD; Wim van Putten, MSc; MD Jesper Jurlander, PhD; MD Jan Andrzej Walewski, Ph.D.; MD Geir Tjonnfjord, PhD; MD Maija Itälä-Remes, PhD; MD Eva Kimby, PhD; doc. MUDr. Tomáš Kozák, Ph.D., MBA; MD Aaron Polliack; MD Shulamiet Wittebol; Fokje Spoelstra, PhD; MD Marinus H.J. Van Oers, PhD
Číslo abstraktu: 290

642. CLL - Therapy, excluding Transplantation: Poster I

Correlations Between Ofatumumab Exposure and Treatment Outcomes for Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Frontline Ofatumumab, Fludarabine, and Cyclophosphamide Chemoimmunotherapy

Autoři: MD William G. Wierda, PhD; Roxanne C Jewell, PhD; MD Thomas J. Kipps, PhD; MD Jan Dürig; M.D. Laimonas Griskevicius (Griškevičius); MD Stephan Stilgenbauer; MUDr. Lukáš Smolej, Ph.D.; MD Georg Hess; MD Francisco J. Hernandez-Ilizaliturri; MBBS, MD Swaminathan Padmanabhan; Lei Fang; Michele M. Gorczyca, MS; MD Geoffrey (W.) Chan; MD Ira (V.) Gupta; MD Steen Lisby, DMSc
Číslo abstraktu: 1793
Kategorie: Maligní lymfomy a leukémie

642. CLL - Therapy, excluding Transplantation: Poster II

Second-Line Therapies After Treatment with Fludarabine, Cyclophosphamide, and Rituximab (FCR) or Fludarabine and Cyclophosphamid Alone (FC) for Chronic Lymphocytic Leukemia (CLL) within the CLL8-Protocol of the German CLL Study Group (GCLLSG)

Autoři: MD Paula Cramer; MD Anna-Maria Fink; Dipl.Math. Raymonde Busch, Ph.D.; MD Barbara Eichhorst; MD Clement Martin Wendtner; MD Natali Pflug; Frederike Schubert; Prof. Dr. med. Hartmut Döhner (Doehner); MD Michael Rieger; MD Michael Kneba, PhD; prof. MUDr. Jiří Mayer, CSc.; Prof. MD Michael Hallek; M.D. Kirsten Fischer
Číslo abstraktu: 2863
Kategorie: Maligní lymfomy a leukémie

651. Myeloma - Biology and Pathophysiology, excluding Therapy: Poster I

Centrosomal Disruption As Early Event in Myeloma Development

Autoři: doc. RNDr. Sabina Ševčíková, Ph.D.; MUDr. Fedor Kryukov; MUDr. Elena Dementyeva; Mgr. Lenka Bešše (Kubiczková); Mgr. Pavel Němec; prof. MUDr. Zdeněk Adam, CSc.; prof. MUDr. Roman Hájek, CSc.
Číslo abstraktu: 1806
Kategorie: Mnohočetný myelom

651. Myeloma - Biology and Pathophysiology, excluding Therapy: Poster II

Regulatory T Cells Predicts Progression in Previously Untreated Myeloma Patients and Treatment by Cyclophosphamide, Thalidomide Plus Dexamethasone Reduces Regulatory T Cells

Autoři: Mgr. Karthick Raja Muthu Raja; Mgr. Lucie Říhová, PhD.; Bc. Petra Májková (Kaisarová); MvDr. Jana Bartoňová; prof. MUDr. Roman Hájek, CSc.
Číslo abstraktu: 2870
Kategorie: Mnohočetný myelom

Impact of 1q21 Amplification Alone and in Combination with Other Genetic Abnormalities on Outcome in Multiple Myeloma Patients Treated with Thalidomide-Based Regimens

Autoři: MD Norbert Grzasko, PhD; MD Marek Hus, PhD; MD Marta Morawska, PhD; prof. MUDr. Roman Hájek, CSc.; Anna Dmoszynska
Číslo abstraktu: 2874
Kategorie: Mnohočetný myelom

653. Myeloma - Therapy, excluding Transplantation I

A Phase 3 Study Evaluating the Efficacy and Safety of Lenalidomide (Len) Combined with Melphalan and Prednisone Followed by Continuous Lenalidomide Maintenance (MPR-R) in Patients (Pts) ≥ 65 Years (Yrs) with Newly Diagnosed Multiple Myeloma (NDMM)

Autoři: MD Antonio P. Palumbo; prof. MUDr. Zdeněk Adam, CSc.; MD Martin (H.) Kropff; Robert (Robin) Foa (Foà); MBBS John V. Catalano, FRACP FRCPA; MD Heinz Gisslinger; Prof. Dr. Wieslaw Wiktor-Jedrzejczak, PhD; MD Michel Delforge, PhD; MD Katja C. Weisel; MD Nicola Cascavilla; MD Jan van Droogenbroeck, PhD; MD Genadi Iosava; MD Michele Cavo; Prof. Dr. Joan Bladé, PhD; prof. MD Meral Beksac; Prof.MUDr. Ivan Špička, PhD; MD Torben Plesner; Zhinuan Yu, PhD; Lindsey Herbein; MD Jay M. Mei, PhD; Christian J. Jacques; Meletios Athanasios Dimopoulos, MD
Číslo abstraktu: 475
Kategorie: Mnohočetný myelom

Continued Overall Survival Benefit After 5 Years’ Follow-up with Bortezomib-Melphalan-Prednisone (VMP) Versus Melphalan-Prednisone (MP) in Patients with Previously Untreated Multiple Myeloma, and No Increased Risk of Second Primary Malignancies...

Autoři: Prof. M.D. Jesús San Miguel, Ph.D.; MD Rudolf Schlag; MD Nuriet K. Khuageva; Meletios Athanasios Dimopoulos, MD; MD Ofer Shpilberg, MPH; MD Martin (H.) Kropff; Prof.MUDr. Ivan Špička, PhD; MD Maria Teresa Petrucci; MD Antonio P. Palumbo; MD Olga S Samoilova; Anna Dmoszynska; Prof. Kudrat M Abdulkadyrov; MD Michel Delforge, PhD; Bin Jiang; MD Maria-Victoria Mateos, PhD; MD Kenneth C. Anderson; MD Dixie-Lee Esseltine, FRCPC; Kevin Liu, PhD; William M Deraedt, PhD; MD Andrew Z. Cakana, FRCPath; MD Helgi van de Velde, PhD; MD Paul Gerard Guy Richardson
Číslo abstraktu: 476
Kategorie: Mnohočetný myelom

653. Myeloma - Therapy, excluding Transplantation: Novel drugs in relapsed/refractory myeloma patients

Vantage 088: Vorinostat in Combination with Bortezomib in Patients with Relapsed/Refractory Multiple Myeloma: Results of a Global, Randomized Phase 3 Trial

Autoři: Meletios Athanasios Dimopoulos, MD; Sundar Jagannath; MD Sung-Soo Yoon, PhD; MD David Samuel diCapua Siegel, PhD; Prof. MD Sagar Lonial; prof. MUDr. Roman Hájek, CSc.; MD Thierry Facon; MD Laura Rosiñol, PhD; MD Hilary Anne Blacklock; Prof. Dr. med. Hartmut Goldschmidt; Vânia Tietsche de Moraes Hungria; MD Andrew Spencer; MD Antonio P. Palumbo; MD Donna E. Reece, FRCPC; MD Thorsten Graef, PhD; Jeniffer Houp; Linda Sun, PhD; MD Joseph E. Eid; MD Kenneth C. Anderson
Číslo abstraktu: 811
Kategorie: Mnohočetný myelom

653. Myeloma - Therapy, excluding Transplantation: Poster II

Preliminary Results of a Phase 2 Study of PD 0332991 in Combination with Bortezomib and Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma

Autoři: MD Ruben Niesvizky; MD Luciano J. Costa, PhD; MD Nisreen A. Haideri; MD Georg Hess; MD Seema Singhal, PhD; Prof.MUDr. Ivan Špička, PhD; MD Edward A. Stadtmauer; MD Ashraf Z. Badros; Marc S. Raab; John L. Jakubczak, PhD; Sindy T. Kim, BS; MD Sophia Randolph, PhD; MD Scott A. Ely; Selina Chen-Kiang, PhD
Číslo abstraktu: 2640

Bortezomib-Bendamustine-Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma (MM) Shows Marked Efficacy and Is Well Tolerated, but Assessment of PNP Symptoms Shows Significant Discrepancies Between Patients and Physicians

Autoři: Prof. MD Heinz Ludwig; MD Hedwig Kasparu; Univ.-Prof. Dr.med.univ. Werner Linkesch; Dr. Josef Thaler, Ph.D.; MD Richard Greil, Ph.D.; MD Clemens Leitgeb; Daniel Heintel; Elisabeth Rauch; Dr. Niklas Zojer; prof. MUDr. Luděk Pour, Ph.D.; Adelheid Seebacher; prof. MUDr. Zdeněk Adam, CSc.
Číslo abstraktu: 2928
Kategorie: Mnohočetný myelom

653. Myeloma - Therapy, excluding Transplantation: Poster III

Melphalan, Prednisone and Lenalidomide Followed by Lenalidomide Maintenance Displays Treatment Characteristics Favourable to Global Quality of Life in Newly Diagnosed Multiple Myeloma (NDMM) Patients ≥ 65 Years

Autoři: Meletios Athanasios Dimopoulos, MD; MD Antonio P. Palumbo; prof. MUDr. Roman Hájek, CSc.; MD Martin (H.) Kropff; MD Maria Teresa Petrucci; Philip Lewis, PhD; Stefanie Millar; Jingshan Zhang, PhD; MD Jay M. Mei, PhD; MD Michel Delforge, PhD
Číslo abstraktu: 3988
Kategorie: Mnohočetný myelom

711. Cell Collection and Processing: Poster I

Plerixafor Is Highly Effective for the Mobilization of Autologous PBSC for Transplant in Children Failing to Mobilize by Conventional Means: International Experience with 40 Children From 19 Centers

Autoři: MD Shalini Shenoy; Kenneth W. Douglas, MD, FRCP, FRCPath; MUDr. Zdeněk Kořístek; MBBS Peter J. Shaw, FRACP,MA,MRCP; MD Jerry Stein; MD Mohamad Mohty, PhD; MD Julián Sevilla; MD Karoline Ehlert; Tracey O'Brien; MD Catherine Roberts; MD Anselm Lee; MD Michael Albert; MD Martin Ebinger; MD Tina Carter; Jairam Sastry, FRCP,FRCPath; MD David Loeb, PhD; MD Mehmet F. Ozkaynak; Jignesh Dalal; Caron Strahlendorf; MD Rakesh K Goyal, MRCP; MD Rafael F. Duarte, PhD
Číslo abstraktu: 1931
Kategorie: Maligní lymfomy a leukémie

Plerixafor for Autologous Peripheral Blood Stem Cell Mobilization in Patients Previously Treated with Fludarabine or Lenalidomide

Autoři: Florent Malard; MD Nicolaus Kröger; MD Ian H. Gabriel; MD Kai Hübel; Prof. Jane F. Apperley, MBChB, MD, FRCP, FRCPath; MD Grzegorz Basak, PhD; Kenneth W. Douglas, MD, FRCP, FRCPath; MD Catarina Geraldes; MD Ozren Jaksic, PhD; MUDr. Zdeněk Kořístek; MD Francesco Lanza; MD Roberto M. Lemoli; MD Gabor Mikala, PhD; MD Dominik Selleslag; MD Nina Worel; MD Rafael F. Duarte, PhD; MD Mohamad Mohty, PhD
Číslo abstraktu: 1932
Kategorie: Maligní lymfomy a leukémie

711. Cell Collection and Processing: Poster II

Stem Cell Mobilization in Poor Mobilizers Using Plerixafor and G-CSF with or without Chemotherapy: A European Perspective

Autoři: MD Maximilian M. Fresen; MD Rafael F. Duarte, PhD; Prof. Jane F. Apperley, MBChB, MD, FRCP, FRCPath; MD Grzegorz Basak, PhD; Kenneth W. Douglas, MD, FRCP, FRCPath; MD Ian H. Gabriel; MD Catarina Geraldes; Branimir Jaksic; MUDr. Zdeněk Kořístek; MD Nicolaus Kröger; MD Francesco Lanza; MD Roberto M. Lemoli; MD Gabor Mikala, PhD; MD Dominik Selleslag; MD Nina Worel; Florian Lange; MD Mohamad Mohty, PhD; MD Kai Hübel
Číslo abstraktu: 2993
Kategorie: Maligní lymfomy a leukémie

721. Clinical Allogeneic Transplantation - Conditioning Regimens, Engraftment and Acute Transplant Toxicities: Acute Transplant Toxicities: Poster II

Intravenous Busulfan (IV Bu)-Based Conditioning Regimen Before Allogeneic Stem Cell Transplantation (allo-SCT) for Adults with Acute Lymphoid Leukemia (ALL): A Aurvey From the Acute Leukemia Working Party of EBMT

Autoři: MD Mohamad Mohty, PhD; MD Myriam Labopin, MS; MD Miguel A. Sanz, PhD; Rose-Marie Hamljadi; MUDr. Vladimír Koza (1954 - 2012); MD William Arcese; MD Antonio Campos; MD Noel-Jean Milpied, Ph.D.; MD Arnon Nagler, MSc.
Číslo abstraktu: 3005
Kategorie: Maligní lymfomy a leukémie

Prognostic Pre-Transplant Factors in Myelodysplastic Syndromes Primarily Treated by Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study on Behalf of the MDS Subcommittee of the Chronic Leukaemia Working Party of the EBMT

Autoři: Eline Cremers; Anja van Biezen; Liesbeth C. de Wreede, Ph.D.; Marijke Scholten; MUDr. Antonín Vítek; Prof. Dr. med. Jürgen Finke; MD Uwe Platzbecker; M.D. Dietrich W. Beelen; M.D. Rainer Schwerdtfeger; MD Liisa Volin, Ph.D.; Nicholas Harhalakis; Anton Schattenberg; MD Arnon Nagler, MSc.; MD Theo de Witte, PhD; MD Nicolaus Kröger
Číslo abstraktu: 3014
Kategorie: Maligní lymfomy a leukémie

722. Clinical Allogeneic Transplantation - Acute and Chronic GVHD, Immune Reconstitution: Poster III

Dual Production of IL-2 and IFN-Gamma by CMV-Specific CD8+ T-Cells Is a Hallmark of Their Ability to Control CMV Reactivation in Patients After Hematopoietic Stem Cell Transplantation

Autoři: prof. MUDr. Tomáš Kalina, Ph.D.; MUDr. Ladislav Król; Mgr. Jan Stuchlý; MUDr. Petra Keslová; MUDr. Petr Hubáček; Bc. Ondřej Pelák; prof. MUDr. Petr Sedláček, CSc.; prof. MUDr. Jan Starý, DrSc.; Prof. MUDr. Ondřej Hrušák, Ph.D.
Číslo abstraktu: 4081

723. Clinical Allogeneic and Autologous Transplantation - Late Complications and Approaches to Disease Recurrence: Poster I

High-Dose Therapy and Autologous Hematopoietic Stem Cell Transplantation (ASCT) Has a Significant but Transient Impact on Quality of Life: Lessons From the Chronic Lymphocytic Leukemia (CLL) ASCT Study by the CLL Subcommittee of the Chronic Leukem...

Autoři: Liesbeth C. de Wreede, Ph.D.; Maggie Watson; MD Donald Milligan, MBChB; MD Mauricette Michallet, Ph.D.; Prof. Dr.med. Peter Dreger; Marleen van Os; Claire E. Dearden; Catherine Cordonnier; MD Michel Leporrier; MUDr. Vladimír Koza (1954 - 2012); Janis Homewood; MD Bernadette Corront; MD Gabriela M. Baerlocher; Wolfgang Herr; MD Dietger W Niederwieser; Laurent Sutton; MD Theo M. de Witte; MD Johannes Schetelig, MSC
Číslo abstraktu: 1989

731. Clinical Allogeneic and Autologous Transplantation - Results: Allogeneic Hematopoietic Stem Cell Transplantation (Myeloid Leukemias)

A Strong Immune Effect by Allogeneic Stem Cell Transplantation May Improve Survival in AML Patients with a High Ratio of the FLT3-ITD Mutation to the Wt-FLT3 Allele: Results from an Analysis of 257 Patients Treated in the SAL AML-2003 Trial

Autoři: MD Gerhard Ehninger; Prof. Dr. Martin Bornhaeuser (Bornhäuser); Michael Kramer; MD Christoph Röllig; Hannes Wandt; MD Mathias Hänel; MD Hermann Einsele; Walter E. Aulitzky; MD Norbert Schmitz; MD Wolfgang E. Berdel; MD Matthias Stelljes; Joachim Kienast; Eckhard Thiel; Andreas Mackensen; MD Uwe Platzbecker; MD Marcus Schaich; MD Johannes Schetelig, MSC; prof. MUDr. Jiří Mayer, CSc.; Prof. MD Hubert Serve; Prof.MD Anthony D. Ho, PhD, FRCP; M.D. Christian Thiede
Číslo abstraktu: 497
Kategorie: Maligní lymfomy a leukémie

731. Clinical Allogeneic and Autologous Transplantation - Results: Poster III

First Interim Safety Analysis of a Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated by Autologous Hematopoietic Stem Cell Transplant

Autoři: MD Francesco Annibale d'Amore, SMSci; M.D. Maria Gomes da Silva, Ph.D.; prof. Sirpa Leppä; Thomas Relander; Antonio Pezzutto; Grete Fossum Lauritzsen; Eckhart Weidmann; Michel Van Gelder; Mats Merup; Hans Hagberg; Unn-Merete Fagerli; Peter de Nully Brown; Per Boye Hansen; Jose Mario Mariz; MUDr. Milada Jankovská; MD Jan Andrzej Walewski, Ph.D.; MD Jeanette K Doorduijn, PhD; Achiel Van Hoof; Ilse Christiansen; Sirkku Jyrkkiö; Johanna C. Kluin-Nelemans; Marinus van Marwijk Kooy; Rob Fijnheer; Wendy Stevens; Jose Zijlstra, MD; L. Böhmer; Pieternella J. Lugtenburg; Matthias Grube; MUDr. Vít Procházka, Ph.D.; MUDr. David Šálek, Ph.D.; MD Richard Greil, Ph.D.; Lorenz Trümper; Gerald Wulf; Bettina Altmann; Marita Ziepert; Markus Loeffler; Esa Jantunen; Georg Hopfinger; M.D. Eric Van den Neste, Ph.D.; Helle Toldbod
Číslo abstraktu: 4110
Kategorie: Chemoterapie; Maligní lymfomy a leukémie

Therapy-Related Myelodysplastic Syndrome Following Treatment for Childhood Acute Lymphoblastic Leukemia: Outcome of Patients Registered in the EWOG-MDS 98/06 Studies

Autoři: MD Brigitte Strahm; MD Roland Amann; MD Barbara De Moerloose; Prof. MD Michael Dworzak; Prof. MD Henrik Hasle; MD Markus Schmugge (Schmugge-Liner); prof. MUDr. Jan Starý, DrSc.; MD Marry M. van den Heuvel-Eibrink, PhD; MD Marco Zecca; Prof. MD Brigitte M. Schlegelberger; Prof. MD Franco Locatelli, PhD; Prof. MD Charlotte M. Niemeyer, PhD
Číslo abstraktu: 4130
Kategorie: Myelodysplastický syndrom

901. Health Services and Outcomes Research: Poster II

Melphalan, Prednisone and Lenalidomide Followed by Lenalidomide Maintenance Improves Health-Related Quality of Life (HRQoL), with Newly Diagnosed Multiple Myeloma (NDMM) Patients ≥ 65 Years Benefiting From Delays in Disease Progression

Autoři: Meletios Athanasios Dimopoulos, MD; MD Michel Delforge, PhD; prof. MUDr. Roman Hájek, CSc.; MD Martin (H.) Kropff; MD Maria Teresa Petrucci; Philip Lewis, PhD; Stefanie Millar; Jingshan Zhang, PhD; MD Jay M. Mei, PhD; MD Antonio P. Palumbo
Číslo abstraktu: 3157
Kategorie: Mnohočetný myelom